EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent

…, L Moris, DE Oprea-Lager, HG van der Poel… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent

…, HG van der Poel, TH van der Kwast… - European urology, 2017 - Elsevier
Henk G. van der Poel is a company consultant for Intuitive Surgical and participates in trials
for Astellas and Steba Biotech. He receives grants/research support from Astellas. Olivier …

EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer

…, L Moris, DE Oprea-Lager, HG van der Poel… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer

…, MD Mason, HG van der Poel, TH van der Kwast… - European urology, 2017 - Elsevier
… van der Poel is a company consultant for Intuitive Surgical, has participated in trials for Astellas
and Steba Biotech, has received grant and research support from Astellas. O. Rouvière is …

Urine markers for bladder cancer surveillance: a systematic review

BWG Van Rhijn, HG Van der Poel, TH van Der Kwast - European urology, 2005 - Elsevier
INTRODUCTION:: The follow-up of patients with urothelial cell carcinoma (UCC) of the
bladder is done by cystoscopy and, in most cases, cytology. The last decade, many urine-based …

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial

…, C van Rooijen, D Peters, A Broeks, HG van der Poel… - Nature medicine, 2020 - nature.com
Preoperative immunotherapy with anti-PD1 plus anti-CTLA4 antibodies has shown
remarkable pathological responses in melanoma 1 and colorectal cancer 2 . In NABUCCO (…

The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review

…, VB Matveev, HG van der Poel, TH van der Kwast… - European urology, 2017 - Elsevier
… Matveev o , Henk G. van der Poel p , Theo H. van der Kwast q , Olivier Rouvière r , Ivo G.
Schoots s t , Thomas Wiegel u , Thomas B. Lam v w … Steven Joniau c …

Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging …

HG van der Poel, T Buckle, OR Brouwer, RAV Olmos… - European urology, 2011 - Elsevier
… Author contributions: Henk G. van der Poel and Fijs WB van Leeuwen had full access to
all the data in the study and take responsibility for the integrity of the data and the accuracy of …

What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis …

…, TH van der Kwast, VB Matveev, HG van der Poel… - European urology, 2017 - Elsevier
Context It remains unclear whether patients with a suspicion of prostate cancer (PCa) and
negative multiparametric magnetic resonance imaging (mpMRI) can safely obviate prostate …

Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review

…, IG Schoots, TH van Der Kwast, HG van Der Poel… - European urology, 2019 - Elsevier
… HG van Der Poel is a company consultant for Intuitive Surgical, has participated in trials
for Astellas and Steba Biotech, and has received grant and research support from Astellas. P. …